← All companies
ELTP
Elite Pharmaceuticals, Inc.
$0.37
+0.00 0.00%
Key statistics
from XBRL data in SEC filingsMarket cap
$399M
Revenue (TTM)
$149M
Net income (TTM)
$44.9M
EPS (TTM)
$0.03
P/E ratio
12.3
Dividend yield
—
Free cash flow
$22.8M
Cash
$30.3M
Total assets
$138M
Gross margin
50.4%
52-week range
$0.33 – $0.74
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Results of operations (earnings release); Regulation FD disclosure
Jun 29, 2026
10-K
Fiscal year ended 2026-03-31
Jun 29, 2026
8-K
Regulation FD disclosure
Jun 23, 2026
8-K
Regulation FD disclosure
Jun 15, 2026
8-K
Regulation FD disclosure
Jun 1, 2026
8-K
Regulation FD disclosure
Apr 2, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
Feb 17, 2026
10-Q
Quarter ended 2025-12-31
Feb 17, 2026
8-K
Regulation FD disclosure
Feb 11, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
Nov 14, 2025
10-Q
Quarter ended 2025-09-30
Nov 14, 2025
8-K/A
Regulation FD disclosure
Nov 12, 2025
8-K
Regulation FD disclosure
Nov 12, 2025
8-K
Regulation FD disclosure
Nov 10, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Aug 14, 2025
10-Q
Quarter ended 2025-06-30
Aug 14, 2025
8-K
Regulation FD disclosure
Aug 8, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Jun 30, 2025
10-K
Fiscal year ended 2025-03-31
Jun 30, 2025
8-K
Regulation FD disclosure
Jun 23, 2025
8-K
Regulation FD disclosure
Jun 16, 2025
8-K
Regulation FD disclosure
Apr 30, 2025
8-K
Regulation FD disclosure
Mar 3, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Feb 13, 2025
10-Q
Quarter ended 2024-12-31
Feb 13, 2025
8-K
Regulation FD disclosure
Dec 26, 2024
8-K
Regulation FD disclosure
Dec 2, 2024
8-K
Regulation FD disclosure
Nov 18, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Nov 14, 2024
10-Q
Quarter ended 2024-09-30
Nov 14, 2024
8-K
Regulation FD disclosure
Oct 10, 2024
8-K
Regulation FD disclosure
Oct 7, 2024
8-K
Regulation FD disclosure
Aug 27, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Aug 14, 2024
10-Q
Quarter ended 2024-06-30
Aug 14, 2024
8-K
Results of operations (earnings release); Regulation FD disclosure
Jul 1, 2024
10-K
Fiscal year ended 2024-03-31
Jul 1, 2024
8-K
Entered a material agreement
Jun 21, 2024
8-K
Changed accountants
Jun 5, 2024
8-K
Regulation FD disclosure
May 20, 2024